News

Bernal León, Mafalda Viana and Sabine E. Hutter et al. Zoonotic Alphaviruses in Costa Rica: Long-Term IgM Serosurveillance in Horses from 2009–2019. Zoonoses. 2025. Vol. 5 (1). DOI: ...
Sujan Shresta, Ph.D. will receive more than $2.4 million from the National Institute of Allergy and Infectious Diseases to help test experimental vaccine strategies against deadly viruses from the ...
Encephalitic alphaviruses (EEVs), Traumatic Brain Injuries (TBI), and organophosphorus nerve agents (NAs) are three diverse biological, physical, and chemical injuries that can lead to long-term ...
WEST LAFAYETTE, Ind. — There is no cure for the common cold. But there are cures — or at least vaccines — for other viruses, and researchers are working hard to build a toolbox to be able to rapidly ...
BioWorld - Tuesday, June 24, 2025 Breaking News: Trump administration impacts continue to roil the life sciences sector See today's BioWorld Science Home » OHSU and the Southern Research Institute ...
A world-renowned expert on alphaviruses, acute encephalitis, measles, HIV, and malaria, Griffin was one of the most prominent scientific leaders of her generation. Her contributions to the field ...
So it’s from a different family of viruses to the flaviviruses (which includes dengue, Japanese encephalitis and Murray Valley encephalitis viruses) and alphaviruses (chikungunya, Ross River and ...
Several significant outbreaks of Ross River virus occurred in the last decade. From late 2014 to 2015, an outbreak of approximately 9,500 cases occurred in Queensland, Australia. Then, in 2017 ...
Kimer Med, a Nelson biotech start-up, announced it has signed a contract valued at up to USD$ 750,000 (NZD$ 1.3 million) with Battelle Memorial Institute (Battelle), the world’s largest independent, ...
About Kimer Med Founded by Rick Kiessig and Phil Oliver in 2020, Kimer Med is a biotech start-up, based in Nelson, New Zealand. Backed by a multi-million dollar seed funding round, the company has ...
Aarthi Narayanan, Professor, Biology, received funding for the project: "Further the development of Omaveloxolone and Bardoxolone methyl as broadly effective countermeasures against alphaviruses ...